Tests virtual reality headsets and breathing exercises for asthma patients
Tests virtual reality and breathing exercises in adults with moderate to severe asthma.
Key facts
- Who runs it
- October 6 University
- Where
- Giza, EgyptSee the site
- Trial code
- Registry title
- Effect Of Virtual Reality On Pulmonary Function And Anxiety Levels In Asthmatic Patients
- Status
- Not yet recruiting
- People taking part
- 40 people, planned
- Started
- 30 Aug 2025
- Planned end
- Mar 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Virtual reality glass
- Buteyko Breathing
- Record updated
- 26 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 30 to 40 with moderate to severe asthma that is not well controlled and with moderate anxiety. It tests virtual reality glasses.
- Age
- 30 to 40 years
- Sex
- Men and women can both join.
- Disease stage
- Previously diagnosed bronchial asthma with FEV1 below 80% of the predicted value. Asthma Control Test (ACT) score below 16, meaning uncontrolled asthma.
- Earlier treatment
- People who took part in any pulmonary rehabilitation program cannot join.
- Biomarker or test result
- FEV1 between 60% and 80% of predicted value, or below 60%. FEV1/FVC ratio may be lower than normal (0.75-0.80). Hospital Anxiety and Depression Scale (HADS) score of 11-15, a moderate anxiety or depression level.
Main reasons for not taking part
- Earlier pulmonary rehabilitation program
- Heart or circulation problems such as uncontrolled high blood pressure, uncontrolled irregular heartbeat or a recent ischemic event
- Mental disorders that prevent following the study steps
- Other long-term lung diseases
- Pregnancy, new or current smoking, or a respiratory tract infection
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Both sexes would be previously diagnosed as bronchial asthma with a cut-off score FEV1: Between 60% and 80% of predicted value or less than 60% of predicted value and FEV1/FVC ratio: May be significantly reduced from normal value 0.75-0.80
- The age of the patients will be ranged between 30 and 40 years old
- Asthma Control Test(ACT) will be less than 16 can be successfully used to identify those who will be uncontrolled asthma
- All patients will be assessed by Hospital Anxiety and Depression Scale (HADS) ;A cut-off score of 11-15 a moderate depression/anxiety level
- Patients who are conscious and cooperative
- Patients who are able to understand and follow instruction
Who cannot take part
- Previous participation in any pulmonary rehabilitation program
- Cardiovascular instabilities such as: Uncontrolled hypertension, Uncontrolled arrhythmia and Recent ischemic event
- Mental disorders preventing protocol implementation
- Other chronic respiratory diseases
- Respiratory tract infection
- Pregnant women
- New or current smoker
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 40 years old?
Where in Egypt
- October 6 university hospital outpatient chest departmentGiza, EgyptContact: Karim A Fathy, ProfessorNo longer taking part
About the trial
What the trial wants to find out
The Purpose of the Study This study will be conducted to determine the effect of virtual reality on pulmonary function and anxiety levels in moderate to severe asthmatic patients.
The 2 groups in the trial
- Buteyko breathing exercise groupExisting treatment, for comparison
The participant will participate in Buteyko breathing only twice\\ week for 8 weeks and the session was about 10 min, with their optimal medical treatment,which depending on three steps: Step 1: The ''Control pause (CP)'' breathing test Step 2: Shallow breathing Sit up straight Step 3: Putting it together Take Control pause
Treatment: Buteyko Breathing
- Virtual Reality groupTreatment being tested
The participants will receive 20 min VR and Buteyko breathing along with prescribed medical treatment for 8 weeks , twice \\week. Training depends on two breathing training aspects with 5 breathing cycles for each one, 30 sec rest in between. in form of: Colour Breathing VR program (Box Breathing), LAMINAL VR (Calm).
Treatment: Virtual reality glass
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect Of Virtual Reality On Pulmonary Function And Anxiety Levels In Asthmatic Patients
- Plain-language title
- Tests virtual reality headsets and breathing exercises for asthma patientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07141212, who can take part
- Record updated
- 26 August 2025